ingredients: water/aqua/eau, glycerin, caprylic/capric triglyceride, cetearyl alcohol, dimethicone, isopropyl palmitate, pentylene glycol, glyceryl stearate, persea gratissima (avocado) oil, vitis vinifera (grape) seed oil, potassium cetyl phosphate, citrus aurantium bergamia (bergamot) fruit oil, hydrogenated palm glyceride, 1,2-hexanediol, caprylyl glycol, panthenol, xanthan gum, citrus aurantium dulcis (orange) peel oil, citrus limon (lemon) peel oil, citrus paradisi (grapefruit) peel oil, acrylates/c10-30 alkyl acrylate crosspolymer, bisabolol, sodium phytate, tocopheryl acetate, sodium hydroxide, citrus aurantium dulcis (orange) flower oil, citrus nobilis (mandarin orange) peel oil, citrus tangerina (tangerine) peel oil, sodium pca, sodium lactate, arginine, aspartic acid, pca, glycine, alanine, sodium hyaluronate, serine, valine, isoleucine, proline, threonine, histidine, phenylalanine, limonene, linalool, citral

A small number of clinical trials indicate that oral l-glutamine can reduce the frequency of acute vaso-occlusive complications and hospitalizations in patients with SCD [13, 14], leading to its regulatory approval by the US Food and Drug Administration in 2017
Andreou A, Kopetz S , Maru DM , Chen SS, Zimmitti G, Brouquet A, Shindoh J, Curley SA, Garrett C, Overman MJ, Aloia TA, Vauthey JN
Follow up studies with in vivo [ 13 C 6 ]-glucose tracing on liver and kidney 24 h after AKI revealed 4 major findings: (1) increased flux through glycolysis and the tricarboxylic (TCA) cycle in both kidney and liver